GENEVA, Oct. 5 -- SHANGHAI REGENELEAD THERAPIES CO., LTD. filed a patent application (CN2026/086454) for “POLYPEPTIDE FOR PREVENTING OR TREATING TUMORS, RNA MOLECULE, AND MEDICAL USE”. With publication no. WO/2026/201110, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....